PUBLISHER: The Business Research Company | PRODUCT CODE: 1946624
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946624
A non-invasive ventilator serves as a medical apparatus designed to provide respiratory support to patients without requiring an invasive breathing tube. This method is commonly employed in managing respiratory conditions such as sleep apnea, chronic obstructive pulmonary disease (COPD), and acute respiratory failure.
The primary categories of non-invasive ventilators include continuous positive airway pressure (CPAP), auto-titrating (adjustable) positive airway pressure (APAP), and bi-level positive pressure (BiPAP). CPAP delivers a consistent airway pressure maintained throughout the respiratory cycle, supporting both inhalation and exhalation. These devices utilize electric, pneumatic, and electro-pneumatic power sources and find application in treating conditions such as COPD, asthma, respiratory distress syndrome, pneumonia, among others. Non-invasive ventilation is employed across various settings including hospitals, specialized clinics, home care environments, and ambulatory surgical centers.
Tariffs are influencing the non-invasive ventilators market by increasing costs of imported sensors, control units, turbines, electronic components, and display modules used in CPAP, BiPAP, and APAP devices. Healthcare providers and manufacturers in North America and Europe are most affected due to reliance on imported electronic and pneumatic components, while Asia-Pacific faces cost pressures on export-driven ventilator manufacturing. These tariffs are raising device prices and slowing procurement cycles. At the same time, they are encouraging localized assembly, regional electronics sourcing, and investment in domestic respiratory device manufacturing capabilities.
The non-invasive ventilators market research report is one of a series of new reports from The Business Research Company that provides non-invasive ventilators market statistics, including non-invasive ventilators industry global market size, regional shares, competitors with a non-invasive ventilators market share, detailed non-invasive ventilators market segments, market trends and opportunities, and any further data you may need to thrive in the non-invasive ventilators industry. This non-invasive ventilators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The non-invasive ventilators market size has grown strongly in recent years. It will grow from $3.05 billion in 2025 to $3.27 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to increasing prevalence of COPD and sleep apnea, expansion of home healthcare services, rising hospital respiratory admissions, growing awareness of non-invasive ventilation benefits, availability of compact ventilator designs.
The non-invasive ventilators market size is expected to see strong growth in the next few years. It will grow to $4.42 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to increasing aging population with respiratory disorders, rising demand for remote patient monitoring, expansion of home-based chronic care management, growing adoption of AI-assisted ventilation systems, increasing focus on early respiratory intervention. Major trends in the forecast period include increasing adoption of portable non-invasive ventilators, rising demand for home-based respiratory care devices, growing integration of smart monitoring features, expansion of auto-titrating ventilation technologies, enhanced focus on patient comfort and compliance.
The escalating levels of air pollution are poised to significantly impact the growth trajectory of the non-invasive ventilator market. This pollution, characterized by harmful substances in the atmosphere, adversely affects human health and exacerbates respiratory issues. Non-invasive ventilators serve as critical aids for individuals battling respiratory problems stemming from air pollution. The World Health Organization's June 2023 report highlighted the association of air pollution, both outdoor and household, with 7 million premature deaths annually, further underlining the necessity for such ventilators. Moreover, the substantial economic impact, as emphasized by the World Bank's estimation of $8.1 trillion in health damage caused by air pollution annually, drives the market for non-invasive ventilators.
Major companies operating in the non-invasive ventilator space are increasingly adopting advanced technologies, including the introduction of next-generation neonatal ventilators, to maintain and strengthen their competitive position. These latest neonatal ventilator systems are designed to deliver enhanced non-invasive respiratory support for premature and medically fragile newborns, integrating upgraded features and multiple ventilation modes to improve both safety and clinical effectiveness. For example, in November 2023, Inspiration Healthcare Group PLC, a United Kingdom-based medical technology provider, launched the SLE1500 as the newest addition to its neonatal ventilator portfolio. The device is engineered to support the smallest and most vulnerable infants by delivering effective non-invasive ventilation while safeguarding delicate lung tissue. The SLE1500 combines six non-invasive delivery options within a single platform, including nasal Continuous Positive Airway Pressure (nCPAP) in both flow- and pressure-controlled modes, high-flow oxygen therapy, and manual flow compatible with therapies such as bubble Continuous Positive Airway Pressure. These modes can be further optimized through integrated Pulse Oximetry (SpO2) monitoring and automatic oxygen control (auto FiO2) enabled by the OxyGenie system.
In September 2024, ZOLL Medical Corporation, a U.S.-based company specializing in medical devices and technology solutions, acquired Vyaire Medical for an undisclosed amount. This acquisition positions ZOLL to enhance its product offerings in the non-invasive ventilation (NIV) sector, particularly in light of the increased demand for such devices stemming from the COVID-19 pandemic and ongoing respiratory health issues. Additionally, ZOLL will be able to utilize Vyaire's established technologies and expertise in NIV, further solidifying its competitive stance in the market. Vyaire Medical is a U.S.-based company focused on respiratory care, providing a variety of non-invasive ventilators for different clinical environments.
Major companies operating in the non-invasive ventilators market are ResMed Inc., Teleflex Incorporated, Hamilton Bonaduz AG, HEYER Medical AG, Airon Corporation, Fisher & Paykel Healthcare Limited, Smiths Medical International Ltd., O-Two Medical Technologies Inc., Phoenix Medical Systems Pvt. Ltd., Koninklijke Philips N.V., Dragerwerk AG & Co. KGaA, General Electric Healthcare Co., Magnamed Tecnologia Medica S/A, WILAmed GmbH, Mindray Medical International Limited, Vyaire Medical Inc., GETINGE AB, Medtronic plc, Respironics Inc., medin Medical Innovations GmbH, Comen Medical Instruments Co. Ltd., Lowenstein Medical Technology GmbH + Co. KG, aXcent medical GmbH, Tenko Medical Systems Corp., Beijing Aeonmed Co. Ltd., MEKICS Co. Ltd., Sefam Medical, Allied Healthcare Products Inc., Air Liquide Medical Systems, Pulmodyne Inc., Bunnell Incorporated
North America was the largest region in the non-invasive ventilators market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-invasive ventilators market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the non-invasive ventilators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The non-invasive ventilator market consists of sales of high flow nasal cannula devices, non-invasive ventilation masks and non-invasive circuits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Non-Invasive Ventilators Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses non-invasive ventilators market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for non-invasive ventilators ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The non-invasive ventilators market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.